UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 133

Sortiert nach

Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro

PloS one, 2024-05, Vol.19 (5), p.e0303449-e0303449

2024

Volltextzugriff (PDF)

Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial

The oncologist (Dayton, Ohio), 2024-05, Vol.29 (5), p.e690-e698

2024

Volltextzugriff (PDF)

Effective retreatment with osimertinib in CNS-relapsed epidermal growth factor receptor-mutant non-small cell lung cancer patient following resection and adjuvant osimertinib

Anti-cancer drugs, 2024-01, Vol.35 (1), p.86

2024

Volltextzugriff (PDF)

The pathogenic and colonization potential of Candida africana

Microbes and infection, 2024-01, Vol.26 (1-2), p.105230, Article 105230

2024

Volltextzugriff (PDF)

A New Phenotype in Candida -Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis-Associated Strains

mBio, 2023-04, Vol.14 (2), p.e0010723-e0010723

2023

Volltextzugriff (PDF)

Predictors of survival to immunotherapy and chemoimmunotherapy in non-small cell lung cancer: A meta-analysis

JNCI : Journal of the National Cancer Institute, 2023-01, Vol.115 (1), p.29-42

2023

Volltextzugriff (PDF)

Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial

European journal of nuclear medicine and molecular imaging, 2023-01, Vol.50 (2), p.572-580

2023

Volltextzugriff (PDF)

Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experience

Lung cancer (Amsterdam, Netherlands), 2022-12, Vol.174, p.91-96

2022

Volltextzugriff (PDF)

Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro

Microbiology spectrum, 2022-06, Vol.10 (3), p.e0269621-e0269621

2022

Volltextzugriff (PDF)

Should We Test Cancer Susceptibility Genes in Routinely Used Multigene Panels? A Case of Synchronous Lung Adenocarcinoma and Breast Cancer Associated With Germline CHEK2 Mutation

Clinical lung cancer, 2022-06, Vol.23 (4), p.e283-e284

2022

Volltextzugriff (PDF)

Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System

American journal of clinical dermatology, 2022-03, Vol.23 (2), p.247-255

2022

Volltextzugriff (PDF)

PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors

Tumori, 2022-02, Vol.108 (1), p.47-55

2022

Volltextzugriff (PDF)

PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors

Clinical lung cancer, 2021-09, Vol.22 (5), p.423-431

2021

Volltextzugriff (PDF)

PD-L1 ≥ 50% lung cancer refractory to PD-1 inhibition: the role of salvage chemo-immunotherapy combination

Immunotherapy, 2021-04, Vol.13 (5), p.363-369

2021

Volltextzugriff (PDF)

Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e001865

2021

Volltextzugriff (PDF)

Randomized Pilot Trial of Percutaneous Posterior Tibial Nerve Stimulation Versus Medical Therapy for the Treatment of Low Anterior Resection Syndrome: One-Year Follow-up

Diseases of the colon & rectum, 2020-12, Vol.63 (12), p.1602

2020

Volltextzugriff (PDF)

Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)

British journal of cancer, 2020-07, Vol.123 (1), p.26-32

2020

Volltextzugriff (PDF)

Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma

Clinical genitourinary cancer, 2020-04, Vol.18 (2), p.e83-e90

2020

Volltextzugriff (PDF)

Quality of life with second or third line nab -paclitaxel-based regimens in advanced non-small-cell lung cancer

Future oncology (London, England), 2020-04, Vol.16 (12), p.749-762

2020

Volltextzugriff (PDF)

Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report

Clinical lung cancer, 2020-03, Vol.21 (2), p.e45-e48

2020

Volltextzugriff (PDF)

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

The lancet oncology, 2019-12, Vol.20 (12), p.1655-1669

2019

Volltextzugriff (PDF)

Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS‐P WT GIST

Genes chromosomes & cancer, 2019-09, Vol.58 (9), p.636-642

2019

Volltextzugriff (PDF)

Adequacy of endosonography‐derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer

The clinical respiratory journal, 2019-09, Vol.13 (9), p.590-597

2019

Volltextzugriff (PDF)

Cabozantinib‐related cardiotoxicity: a prospective analysis in a real‐world cohort of metastatic renal cell carcinoma patients

British journal of clinical pharmacology, 2019-06, Vol.85 (6), p.1283-1289

2019

Volltextzugriff (PDF)

The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC

Lung cancer (Amsterdam, Netherlands), 2019-01, Vol.127, p.153-163

2019

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(118)

Publikationsform

Artikel
(133)

Sprache

Englisch
(133)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Humans
(133)
Science & Technology
(123)
Life Sciences & Biomedicine
(120)
Male
(99)
Middle Aged
(99)
Oncology
(99)
Aged
(96)
Adult
(69)
Lung Neoplasms - Drug Therapy
(58)
Lung Neoplasms - Pathology
(50)
Aged, 80 And Over
(45)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(44)
Treatment Outcome
(39)
Biological And Medical Sciences
(36)
Medical Sciences
(35)
Carcinoma, Non-Small-Cell Lung - Pathology
(33)
Neoplasm Staging
(31)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(30)
Chemotherapy
(28)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Lung Cancer
(19)
Tumori
(12)
Journal Of Clinical Oncology
(8)
Cancer
(7)
American Journal Of Clinical Oncology
(6)
Anticancer Research
(5)
Clinical Lung Cancer
(5)
Journal Of Thoracic Oncology
(5)
The New England Journal Of Medicine
(4)
Plos One
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro

Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial

Effective retreatment with osimertinib in CNS-relapsed epidermal growth factor receptor-mutant non-small cell lung cancer patient following resection and adjuvant osimertinib

The pathogenic and colonization potential of Candida africana

A New Phenotype in Candida -Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis-Associated Strains

Predictors of survival to immunotherapy and chemoimmunotherapy in non-small cell lung cancer: A meta-analysis

Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial

Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experience

Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro

Should We Test Cancer Susceptibility Genes in Routinely Used Multigene Panels? A Case of Synchronous Lung Adenocarcinoma and Breast Cancer Associated With Germline CHEK2 Mutation

Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System

PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors

PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors

PD-L1 ≥ 50% lung cancer refractory to PD-1 inhibition: the role of salvage chemo-immunotherapy combination

Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer

Randomized Pilot Trial of Percutaneous Posterior Tibial Nerve Stimulation Versus Medical Therapy for the Treatment of Low Anterior Resection Syndrome: One-Year Follow-up

Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)

Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma

Quality of life with second or third line nab -paclitaxel-based regimens in advanced non-small-cell lung cancer

Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS‐P WT GIST

Adequacy of endosonography‐derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer

Cabozantinib‐related cardiotoxicity: a prospective analysis in a real‐world cohort of metastatic renal cell carcinoma patients

The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC

Aktive Filter

Suchergebnisse filtern